# Approaches to Authenticating Products Containing Red Yeast Rice Extract (Monacolin K)

**Authors:** Stanislava Ivanova, Velislava Todorova, Daniela Grekova-Kafalova, Zoya Dzhakova, Katerina Slavcheva

PMC · DOI: 10.3390/molecules31040723 · Molecules · 2026-02-19

## TL;DR

This paper reviews methods to verify the authenticity and quality of red yeast rice supplements, which are used for cholesterol management but often have inconsistent or unsafe contents.

## Contribution

A multi-level analytical strategy is proposed to authenticate red yeast rice products and detect adulteration.

## Key findings

- Monacolin K in red yeast rice is chemically identical to the drug lovastatin, making it hard to distinguish.
- A combination of targeted and non-targeted analytical techniques improves product authentication and quality assessment.
- Standardized protocols are needed to ensure transparency and safety in the red yeast rice supplement market.

## Abstract

Red yeast rice (RYR) food supplements are widely used for cholesterol management owing to their content of monacolin K (MK), which, in its lactone form, is chemically identical to the prescription statin lovastatin. Despite their popularity, RYR products raise significant quality and safety concerns related to pronounced variability in MK content, frequent labeling non-compliance, contaminations with undeclared pharmaceutical statins, etc. The analytical differentiation between naturally produced MK and added synthetic lovastatin remains particularly challenging due to their identical chemical structures. This review provides a comprehensive overview of the chemical composition of RYR, with emphasis on monacolins, pigments, and relevant secondary metabolites, and critically summarizes current regulatory, safety, and quality issues associated with RYR-based food supplements. Furthermore, a practical, multi-level analytical strategy for product authentication is proposed. The approach integrates targeted quantification of MK and accompanying monacolins, identification of characteristic Monascus pigments as authenticity markers, gas chromatography–mass spectrometry for the detection of undeclared statins and other non-declared constituents, and proton nuclear magnetic resonance for global compositional fingerprinting. By combining complementary targeted and non-targeted techniques, this workflow enables more reliable authentication, detection of adulteration, and comprehensive quality assessment. The implementation of standardized analytical protocols is essential to improve transparency and enhance consumer safety in the rapidly expanding RYR supplement market.

## Linked entities

- **Chemicals:** monacolin K (PubChem CID 53232), lovastatin (PubChem CID 53232)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tas2r146-ps1 (taste receptor, type 2, member 146, pseudogene 1) [NCBI Gene 387516] {aka Tas2r46, mps1}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Tas2r145-ps3 (taste receptor, type 2, member 145, pseudogene 3) [NCBI Gene 387518] {aka Tas2r45, mps3, ps3}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tas2r111-ps2 (taste receptor, type 2, member 111, pseudogene 2) [NCBI Gene 387517] {aka T2R11, mps2}
- **Diseases:** acute and renal toxicity (MESH:D058186), hepatic and extrahepatic carcinogenesis (MESH:D063646), nephro- and neurotoxic (MESH:D020258), injury to (MESH:D014947), inflammatory (MESH:D007249), Fanconi syndrome (MESH:D005198), dyslipidemia (MESH:D050171), kidney dysfunction (MESH:D007674), myalgia (MESH:D063806), hepatitis (MESH:D056486), CVD (MESH:D002318), RYR (MESH:D002181), MK (MESH:D014813), toxicity (MESH:D064420), rhabdomyolysis (MESH:D012206), atherogenesis (MESH:D050197), carcinogenic (MESH:D011230), deaths (MESH:D003643)
- **Chemicals:** Puberulic acid (MESH:C000597460), Citrinin (MESH:D002953), compactin (MESH:C012258), galactose (MESH:D005690), ethanol (MESH:D000431), polyketide (MESH:D061065), cholesterol (MESH:D002784), alpha-linolenic acid (MESH:D017962), Dihydromonacolin L (MESH:C045373), sorbitol (MESH:D013012), MK (MESH:D008148), water (MESH:D014867), monacolin T (MESH:C000626560), genistein (MESH:D019833), Coumarin (MESH:C030123), Terpenoids (MESH:D013729), hydroxy acid (MESH:D006880), monacolin P (MESH:C583101), (+)-monascumic acid (MESH:C484932), N (MESH:D009584), beta-sitosterol (MESH:C025473), lariciresinol (MESH:C060282), Polysaccharides (MESH:D011134), daucosterol (MESH:C011015), polyols (MESH:C024617), carbon (MESH:D002244), Phytosterols (MESH:D010840), 3-epi-betulinic acid (MESH:D000094062), triglyceride (MESH:D014280), citrates (MESH:D002951), monosaccharide (MESH:D009005), monacolin O (MESH:C583100), linoleic acid (MESH:D019787), mannose (MESH:D008358), NaCl (MESH:D012965), metal (MESH:D008670), 2-hydroxyoctadecanoic acid (MESH:C061806), EPS-1 (MESH:C041379), oxygen (MESH:D010100), azaphilones (MESH:C494154), sugars (MESH:D000073893), alpha-cadinol (MESH:C445364), simvastatin (MESH:D019821), monacolin L (MESH:C045375), rubropunctamine (MESH:C510963), lead (MESH:D007854), coumarins (MESH:D003374), scopoletin (MESH:D012603), BAs (MESH:D001464), monascorubramine (MESH:C510964), glucose (MESH:D005947), stigmasterol (MESH:D013265), flavonoids (MESH:D005419), rosuvastatin (MESH:D000068718), monascin (MESH:C517880), beta-sitosteryl palmitate (MESH:C479126), 3alpha-hydroxy-3,5-dihydromonacolin L (MESH:C067078), xylose (MESH:D014994), arabinose (MESH:D001089), Sterols (MESH:D013261)
- **Species:** Monascus purpureus (species) [taxon 5098], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Penicillium citrinum (species) [taxon 5077], Glycine max (soybean, species) [taxon 3847], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Homo sapiens (human, species) [taxon 9606], Dioscorea (genus) [taxon 4672]
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), RYR — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_C4MV)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942876/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942876/full.md

## References

96 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942876/full.md

---
Source: https://tomesphere.com/paper/PMC12942876